Task order 18:production of triapine injection product for clinical use
Ended Awarded Last action
- Contract number
- HHSN26100018
- Awardee
-
Societal Cdmo San Diego, LLC UEI YRPTVKHDL7Z5 Part of Irisys, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $179,379
Award facts
- Opportunity
-
- N02CM5700205 Solicitation number
- Manufacture of Oral and Topical Dosage Forms Award Notice · Posted Jul 6, 2015
- Manufacture of Oral and Topical Dosage Forms Award Notice · Posted Jan 6, 2015
- Contract value 100% obligated
- $179,379.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Original award | $179,379 |
About this award
This is a task order awarded under the National Cancer Institute (NCI)'s $45 million Drug Formulation and Manufacturing Contracts 2019 multiple-award Indefinite Delivery Vehicle (IDV). The task order, valued at $179,379.00, was awarded to Societal CDMO San Diego, LLC (doing business as Irisys Inc.), a self-certified small disadvantaged business and limited liability company.
The task order is for the production of the Triapine Injection product for clinical use. Societal CDMO San Diego, a contract development and manufacturing organization (CDMO), will provide pharmaceutical development, manufacturing, and testing services to support the NCI's cancer research efforts. This includes producing various drug formulations, such as injectable solutions, for investigational new drugs and clinical trials. Societal CDMO San Diego has previously supported the NCI and other HHS agencies with the production of compounds like metarrestin, z-endoxifen, AZA-TDC, and TAK-243. The company also holds IDVs with the Department of Veterans Affairs for the production and supply of imiquimod cream formulations for cancer prevention research.
Quick answers
Who was awarded contract HHSN26100018?
HHSN26100018 was awarded to Societal Cdmo San Diego, LLC by National Cancer Institute (National Institutes of Health) on February 10, 2017.
How much is contract HHSN26100018 worth?
The government has obligated $179,379 on HHSN26100018.
Is contract HHSN26100018 an order under another contract?
Yes. HHSN26100018 is a delivery order under HHSN261201500009I, an indefinite delivery contract.
Was contract HHSN26100018 competed?
The extent of competition for HHSN26100018 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award